Johnston John Joseph's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Nov 16, 2023
- Accession no.
- 0001209191-23-055540
- Filed
- Nov 16, 2023
- Trade date
- Nov 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $37.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnston John JosephCIK 0001874850 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Common Stock | MOption exerciseAcquired | +8,717 | $1.64 | +$14,295.88 | 129,300 | Direct | |
| Nov 14, 2023 | Common Stock | MOption exerciseAcquired | +1,283 | $2.14 | +$2,745.62 | 130,583 | Direct | |
| Nov 14, 2023 | Common Stock | SSaleDisposed | −10,000 | $3.71 | −$37,100 | 120,583 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Common Stock | MOption exerciseDisposed | −8,717 | $0.00 | $0 | 0 | Direct | |
| Nov 14, 2023 | Common Stock | MOption exerciseDisposed | −1,283 | $0.00 | $0 | 25,617 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.